Humacyte to Report Third-Quarter Results and Provide Business Update November 10
Humacyte said it will release financial results for the three months ended in its third quarter of 2026 and provide a business update on November 10.
DURHAM, N.C, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. NASDAQ:HUMA, a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company will release its financial results for the three months…